MedPath

Clinical trial of autologous adiose tissue derived stromal cell therapy for ischemic heart failure

Not Applicable
Conditions
Ischemic heart failure
Registration Number
JPRN-UMIN000009066
Lead Sponsor
Kanazawa University
Brief Summary

Performed 4 cases. Safety and clinical benefit were confirmed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
4
Inclusion Criteria

Not provided

Exclusion Criteria

*Complicated severe other organ disease. *Patient with malignancy. *History of chemotherapy or irradiation within 4 weeks. *Patient with immunodeficiency *Pregnancy or possibility of pregnancy *Candidate who are judged to be not applicable to this study by doctors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assesment of safety in the context of adverse events defined in the implementation protocol.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath